Ironwood Pharmaceuticals IRWD
NASDAQ IRWD
$4.07 -0.10 (-2.40%)
As of: Sep 9, 2026 · 3:59 PM EDT

Ironwood Pharmaceuticals (IRWD) Goodwill & Intangibles (2016 - 2026)

Ironwood Pharmaceuticals' (IRWD) quarterly Goodwill & Intangibles came in at $1.6 million in Q2 2026, down 33.43% year-over-year from $2.5 million in Q2 2025, and down 11.15% quarter-over-quarter from $1.8 million in Q1 2026.

Analysis

Ironwood Pharmaceuticals (IRWD) Goodwill & Intangibles (2016 - 2026) Analysis & Trends

Ironwood Pharmaceuticals has disclosed Goodwill & Intangibles across 8 years of filings, most recently posting $1.6 million for Q2 2026.

  • In Q2 2026, Goodwill & Intangibles fell 33.43% year-over-year to $1.6 million; the TTM figure through Jun 2026 stood at $1.6 million (down 33.43% YoY), while the FY2025 annual figure was $2.0 million, down 28.67% from the prior year.
  • Goodwill & Intangibles came in at $1.6 million for Q2 2026 at Ironwood Pharmaceuticals, down from $1.8 million in the prior quarter.
  • In the past five years, Goodwill & Intangibles ranged from a high of $4.1 million in Q2 2023 to a low of $1.6 million in Q2 2026.
  • Average Goodwill & Intangibles over 4 years is $2.9 million, with a median of $2.9 million recorded in 2024.
  • Year-over-year, Goodwill & Intangibles declined 20.09% in 2024 and tumbled 33.43% in 2026.
  • Over 4 years, Goodwill & Intangibles stood at $3.7 million in 2023, then slipped by 22.32% to $2.9 million in 2024, then decreased by 28.67% to $2.0 million in 2025, then fell by 19.95% to $1.6 million in 2026.
  • Per Business Quant data, the three most recent Goodwill & Intangibles figures were $1.6 million in Q2 2026, $1.8 million in Q1 2026, and $2.0 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 211.73 Bn 197.74 Bn 7.24 Bn
2 Gilead Sciences 180.92 Bn 177.74 Bn 6.22 Bn
3 Vertex Pharmaceuticals 132.16 Bn 124.30 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 82.89 Bn 74.90 Bn 3.93 Bn
5 Argenx Se 61.41 Bn 56.23 Bn 1.37 Bn
6 Moderna 53.99 Bn 48.85 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 34.48 Bn 31.18 Bn 992.69 Mn
8 Biogen 31.15 Bn 29.86 Bn 1.96 Bn
9 Roivant Sciences 30.05 Bn 30.05 Bn 1.16 Mn
10 Ironwood Pharmaceuticals 669.13 Mn 590.00 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.63 Mn
Mar 31, 2026 1.84 Mn
Dec 31, 2025 2.04 Mn
Sep 30, 2025 2.25 Mn
Jun 30, 2025 2.45 Mn
Mar 31, 2025 2.66 Mn
Dec 31, 2024 2.86 Mn
Sep 30, 2024 3.07 Mn
Jun 30, 2024 3.27 Mn
Mar 31, 2024 3.48 Mn
Dec 31, 2023 3.68 Mn
Sep 30, 2023 3.89 Mn
Jun 30, 2023 4.10 Mn
Dec 31, 2019 785,000.00
Sep 30, 2019 785,000.00
Jun 30, 2019 785,000.00
Mar 31, 2019 785,000.00
Dec 31, 2018 785,000.00
Sep 30, 2018 785,000.00
Jun 30, 2018 153.74 Mn